Can you outrun DEMENTIA? Exercise-induced hormone reduces Alzheimer’s plaque in lab
- A hormone called irisin released during exercise reduces plaques in the brain
- It causes higher levels of the neprilysin enzyme, which removes amyloid beta
- READ MORE: Scientists launch studies into whether Ozempic can treat dementia
The reason why exercise can prevent Alzheimer’s disease has been discovered and could lead to new treatments for the incurable condition.
Experts have shown that a hormone called irisin, released during exercise, removes plaques in the brain linked to memory-robbing disorder.
In a laboratory study, amyloid beta proteins exposed to irisin showed a “remarkable reduction.”
Exercise has been shown to reduce amyloid beta deposits in several mouse models, but the mechanisms involved have remained a mystery.
Now the study, published in the journal neuronsolves the puzzle and promises new ways to prevent or cure the condition.
Experts have found that a hormone called irisin released during exercise reduces the plaques and tangles in the brain that are thought to cause Alzheimer’s disease.
For example, the researchers said it could boost new potential treatments, such as irisin injected into the bloodstream.
Lead author of the study Dr. Se Hoon Choi, assistant professor of neurology at Massachusetts General Hospital (MGH), said: ‘First, we found that treatment with irisin led to a remarkable reduction in amyloid beta pathology.
‘Second, we have shown that this effect of irisin can be attributed to increased neprilysin activity due to increased levels of neprilysin secreted by cells in the brain called astrocytes.’
The team had previously developed the first 3D model of Alzheimer’s disease: a system of cells built in a laboratory to represent a human brain with the condition.
It had the two main hallmarks of the condition: amyloid beta deposits and tau tangles in the brain.
It was already known that exercise causes the muscles to release irisin, increasing its concentrations in the body.
It improves muscle activity, increasing the amount of energy the muscles can use.
The team applied the hormone to their 3D model of an Alzheimer’s disease human brain.
Neprilysin is an amyloid beta-degrading enzyme found in the brains of mice designed for exercise.
Previous studies have shown that irisin, injected into the bloodstream, can reach the brain in mice, making it potentially useful as a therapeutic agent.
Dr. Rudolph Tanzi, senior author of the study and director of the Genetics and Aging Research Unit at MGH, said: ‘Our findings indicate that irisin is an important mediator of exercise-induced increases in neprilysin levels, leading to reduced amyloid beta burden, indicating a new target route for therapies aimed at the prevention and treatment of Alzheimer’s disease.’